
Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated January 30, 2023, titled " USFDA concludes inspection at Solara s Visakhapatnam (Vizag) facility with zero 483 inspectional observations. ".
Filed with NSE ·

Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated January 30, 2023, titled " USFDA concludes inspection at Solara s Visakhapatnam (Vizag) facility with zero 483 inspectional observations. ".
6ix hasn’t read this filing yet.
Solara Active Pharma Sciences Ltd. on 6ix
Follow Solara Active Pharma Sciences into a list and get an email when it puts out news.
Follow Solara Active Pharma Sciences